Cryptic intronic NBAS variant reveals the genetic basis of recurrent liver failure in a child.
暂无分享,去创建一个
Beryl B. Cummings | H. Hakonarson | Yiran Guo | M. Cowley | J. Christodoulou | A. Compton | Rocio Rius | C. Ellaway | D. Thorburn | N. V. Van Bergen | L. Riley | V. Gayevskiy | Minal Menezes | Louisa Adams
[1] Regina M. Hardison,et al. Liver Transplant Listing in Pediatric Acute Liver Failure: Practices and Participant Characteristics , 2018, Hepatology.
[2] Marcel E Dinger,et al. Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy. , 2018, Journal of the American College of Cardiology.
[3] Abramowicz Anna,et al. Splicing mutations in human genetic disorders: examples, detection, and confirmation , 2018, Journal of Applied Genetics.
[4] T. Illig,et al. Diagnosis of monogenic liver diseases in childhood by next‐generation sequencing , 2018, Clinical genetics.
[5] L. D’Antiga,et al. Next generation sequencing in pediatric hepatology and liver transplantation , 2018, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[6] Marcel E. Dinger,et al. Seave: a comprehensive web platform for storing and interrogating human genomic variation , 2018, bioRxiv.
[7] Zhongji Pu,et al. Targeted next-generation sequencing reveals two novel mutations of NBAS in a patient with infantile liver failure syndrome-2 , 2017, Molecular medicine reports.
[8] F. Tandoi,et al. NBAS mutations cause acute liver failure: when acetaminophen is not a culprit , 2017, Italian Journal of Pediatrics.
[9] Zhong Ren,et al. Annotating pathogenic non-coding variants in genic regions , 2017, Nature Communications.
[10] J. Casanova,et al. Recurrent elevated liver transaminases and acute liver failure in two siblings with novel bi-allelic mutations of NBAS. , 2017, European journal of medical genetics.
[11] Yi Lu,et al. Novel NBAS mutations and fever-related recurrent acute liver failure in Chinese children: a retrospective study , 2017, BMC Gastroenterology.
[12] M. Carmo-Fonseca,et al. Deep intronic mutations and human disease , 2017, Human Genetics.
[13] Clara Gaff,et al. Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement , 2017, Genetics in Medicine.
[14] Winston A Hide,et al. Compound heterozygous variants in NBAS as a cause of atypical osteogenesis imperfecta. , 2017, Bone.
[15] Stephanie Spranger,et al. Acute Liver Failure Meets SOPH Syndrome: A Case Report on an Intermediate Phenotype , 2017, Pediatrics.
[16] Jeffrey M. Weiss,et al. MECR Mutations Cause Childhood-Onset Dystonia and Optic Atrophy, a Mitochondrial Fatty Acid Synthesis Disorder. , 2016, American journal of human genetics.
[17] Clara Gaff,et al. Patient safety in genomic medicine: an exploratory study , 2016, Genetics in Medicine.
[18] Robert W. Taylor,et al. Recurrent acute liver failure due to NBAS deficiency: phenotypic spectrum, disease mechanisms, and therapeutic concepts , 2016, Journal of Inherited Metabolic Disease.
[19] Sheila Unger,et al. NBAS mutations cause a multisystem disorder involving bone, connective tissue, liver, immune system, and retina , 2015, American journal of medical genetics. Part A.
[20] A. Mégarbané,et al. Neuroblastoma Amplified Sequence (NBAS) mutation in recurrent acute liver failure: Confirmatory report in a sibship with very early onset, osteoporosis and developmental delay. , 2015, European journal of medical genetics.
[21] James Y. Zou. Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.
[22] Karl R. Clauser,et al. MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins , 2015, Nucleic Acids Res..
[23] Thomas Meitinger,et al. Biallelic Mutations in NBAS Cause Recurrent Acute Liver Failure with Onset in Infancy , 2015, American journal of human genetics.
[24] H. Hakonarson,et al. Delayed diagnosis of congenital myasthenia due to associated mitochondrial enzyme defect , 2015, Neuromuscular Disorders.
[25] D. Jain,et al. Individual exome analysis in diagnosis and management of paediatric liver failure of indeterminate aetiology. , 2014, Journal of hepatology.
[26] C. Pérez-Cerdá,et al. Functional analysis and in vitro correction of splicing FAH mutations causing tyrosinemia type I , 2014, Clinical genetics.
[27] G. Mazariegos,et al. Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the american association for the study of liver diseases, american society of transplantation and the north american society for pediatric gastroenterology, hepatology and nutrition , 2014, Hepatology.
[28] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[29] Magalie S Leduc,et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.
[30] J. Miller,et al. Predicting the Functional Effect of Amino Acid Substitutions and Indels , 2012, PloS one.
[31] S. Gallati,et al. Molecular and biochemical characterisation of a novel mutation in POLG associated with Alpers syndrome , 2011, BMC neurology.
[32] Erin M. Coffee,et al. Mutations in the promoter region of the aldolase B gene that cause hereditary fructose intolerance , 2010, Journal of Inherited Metabolic Disease.
[33] M. Rivas,et al. Nature Genetics Advance Online Publication High-throughput, Pooled Sequencing Identifies Mutations in Nubpl and Foxred1 in Human Complex I Deficiency , 2022 .
[34] Jana Marie Schwarz,et al. MutationTaster evaluates disease-causing potential of sequence alterations , 2010, Nature Methods.
[35] M. Takagi,et al. Neuroblastoma amplified sequence gene is associated with a novel short stature syndrome characterised by optic nerve atrophy and Pelger–Huët anomaly , 2010, Journal of Medical Genetics.
[36] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[37] D. Grinberg,et al. Antisense oligonucleotide treatment for a pseudoexon‐generating mutation in the NPC1 gene causing Niemann‐Pick type C disease b , 2009, Human mutation.
[38] E. Christensen,et al. Highly variable clinical phenotype of carbamylphosphate synthetase 1 deficiency in one family: an effect of allelic variation in gene expression? , 2009, Clinical genetics.
[39] A. Munnich,et al. The first founder DGUOK mutation associated with hepatocerebral mitochondrial DNA depletion syndrome. , 2009, Molecular genetics and metabolism.
[40] T. Isobe,et al. Identification of the neuroblastoma-amplified gene product as a component of the syntaxin 18 complex implicated in Golgi-to-endoplasmic reticulum retrograde transport. , 2009, Molecular biology of the cell.
[41] Schraga Schwartz,et al. SROOGLE: webserver for integrative, user-friendly visualization of splicing signals , 2009, Nucleic Acids Res..
[42] M. Baumgartner,et al. Identification of novel mutations in the SLC25A15 gene in hyperornithinemia‐hyperammonemia‐homocitrullinuria (HHH) syndrome: A clinical, molecular, and functional study , 2009, Human mutation.
[43] C. Béroud,et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.
[44] Song Zhang,et al. Serum α‐NH2‐butyric acid may predict spontaneous survival in pediatric acute liver failure , 2009, Pediatric transplantation.
[45] A. Ribes,et al. Lethal hepatopathy and leukodystrophy caused by a novel mutation in MPV17 gene: description of an alternative MPV17 spliced form. , 2008, Molecular genetics and metabolism.
[46] H. Willenbring,et al. Argininosuccinate lyase (ASL) deficiency: mutation analysis in 27 patients and a completed structure of the human ASL gene , 2002, Human Genetics.
[47] Tom H. Pringle,et al. The human genome browser at UCSC. , 2002, Genome research.
[48] T. Saheki,et al. Nature and frequency of mutations in the argininosuccinate synthetase gene that cause classical citrullinemia , 1995, Human Genetics.
[49] D. Cox,et al. The Wilson disease gene: spectrum of mutations and their consequences , 1995, Nature Genetics.
[50] M. Grompe,et al. A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I. , 1994, The New England journal of medicine.
[51] C. Wadelius,et al. Galactosemia caused by a point mutation that activates cryptic donor splice site in the galactose-1-phosphate uridyltransferase gene. , 1993, Genomics.
[52] M. Kabra,et al. Molecular Diagnosis of Hereditary Fructose Intolerance: Founder Mutation in a Community from India. , 2015, JIMD reports.
[53] Ann E. Frazier,et al. Biochemical analyses of the electron transport chain complexes by spectrophotometry. , 2012, Methods in molecular biology.
[54] J. Stockman. Acute Liver Failure in Children: The First 348 Patients in the Pediatric Acute Liver Failure Study Group , 2008 .
[55] Y. Takeshima,et al. Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation. , 2007, The Kobe journal of medical sciences.